Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Healthy Volunteers

Clinical trial NCT03641794 · UNKNOWN

Trial details

NCT number: NCT03641794
Sponsor: Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2018-09-07
Primary completion: 2019-05-13
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.